The role of protein tyrosine kinases in CYP1A1 induction by omeprazole and thiabendazole in rat hepatocytes

Life Sciences

Volumn 74, Issue 18, 2004, Pages 2265-2278

  Lemaire, G ^a   Delescluse, C ^a   Pralavorio, M ^a   Ledirac, N ^a   Lesca, P ^a   Rahmani, R ^a  

^a CEMAGREF   (France)

Author keywords

CYP1A1; Omeprazole; Rat hepatocytes; Thiabendazole; Tyrosine kinase

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; AROMATIC HYDROCARBON RECEPTOR; BENZIMIDAZOLE DERIVATIVE; CYTOCHROME P450 1A1; ETHOXYRESORUFIN DEETHYLASE; GENISTEIN; HERBIMYCIN A; LAVENDUSTIN A; LIGAND; MESSENGER RNA; OMEPRAZOLE; PROTEIN DERIVATIVE; PROTEIN TYROSINE KINASE INHIBITOR; TIABENDAZOLE;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; EXPOSURE; INTERMETHOD COMPARISON; LIVER CELL; MALE; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

EID: 1342324016     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.09.056     Document Type: Article

References (38)

1. Aix L., Rey-Grobellet X., Larrieu G., Lesca P., Galtier P. Thiabendazole is an inducer of cytochrome P4501A1 in cultured rabbit hepatocytes. Biochemical and Biophysical Research Communications. 202(3):1994;1483-1489.
2. Backlund M., Johansson I., Mkrtchian S., Ingelman-Sundberg M. Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells. Journal of Biological Chemistry. 272(50):1997;31755-31763.
3. Blankenship A., Matsumura F. 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced activation of a protein tyrosine kinas, pp60src, in murine hepatic cytosol using a cell-free system. Molecular Pharmacology. 52(4):1997;667-675.
4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analytical Pharmacology. 162(1):1987;156-159.
5. Conney A.H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Research. 42(12):1982;4817-4875.
6. Curi-Pedrosa R., Daujat M., Pichard L., Ourlin J.C., Clair P., Gervot L., Lesca P., Domergue J., Joyeux H., Fourtanier G. Omeprazole and lansoprazole are mixed inducers of CYP1A1 and CYP3A in human hepatocytes in primary cultures. The Journal of Pharmacology and Experimental Therapeutics. 269(1):1994;384-392.
7. Daujat M., Peryt B., Lesca P., Fourtanier G., Domergue J., Maurel P. Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor. Biochemical and Biophysical Research Communications. 188(2):1992;820-825.
8. Daulhac L., Kowalski-Chauvel A., Pradayrol L., Vaysse N., Seva C. Gastrin stimulate the formation of a p60Src/p125FAK complex upstream of the phosphatidyinositol 3-kinase signalling pathway. FEBS Letters. 445(2-3):1999;251-255.
9. Denison M.S., Fisher J.M., Whitlock J.P. Jr. Protein-DNA interactions at recognition sites for the dioxin-Ah receptor complex. Journal of Biological Chemistry. 264(18):1989;16478-16482.
10. Enan E., Dunlapp D.Y., Matsumura F. Use of c-Src and c-Fos knockout mice for the studies on the role of c-Src kinase signalling in the expression of toxicity of TCDD. Journal of Biochemical and Molecular Toxicology. 12(5):1998;263-274.
11. Enan E., Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) through the protein phoshorylation pathway. Biochemistry Pharmacology. 52(10):1996;1599-1612.
12. Fontaine F., Delescluse C., de Sousa G., Lesca P., Rahmani R. Cytochrome 1A1 induction by primaquine in human hepatocytes and HepG2 cells: Absence of binding to the Aryl Hydrocarbon Receptor. Biochemical Pharmacology. 57(3):1999;255-262.
13. Fulco R.A., Costa C., Germano M.P., Torre E.A., Viscomi M.G., Salimbeni V., Maisano R., Costa G. Hepatotoxicity of camptothecin derivatives in a primary culture system. Journal Chemotherapy. 12(4):2000;345-351.
14. Gonzalez F.J. The molecular biology of cytochrome P450s. Pharmacology Review. 40(4):1988;243-288.
15. Gonzalez F.J., Fernandez-Salguero P., Ward J.M. The role of the aryl hydrocarbon receptor in animal development, physiological homeostasis and toxicity of TCDD. Journal of Toxicology Science. 21(5):1996;273-277.
16. Gradelet S., Astorg P., Pineau T., Canivenc M.C., Siess M.H., Leclerc J., Lesca P. Ah receptor-dependent CYP1A1 induction by two carotenoids, canthaxanthin and β-apo-8′-carotenal, with no affinity for the TCDD binding site. Biochemical Pharmacology. 54(2):1997;307-315.
17. Hass M., Askari A., Xie Z. Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. The Journal of Biology Chemistry. 275(36):2000;27832-27837.
18. Hsu C.Y., Persons P.E., Spada A.P., Bednar R.A., Levitzki A., Zilberstein A. Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by lavendustin-A and its analogue. Journal of Biological Chemistry. 266(31):1991;21105-21112.
19. Hutchison K.A., Brott B.K., De Leon J.H., Perdew G.H., Jove R., Pratt W.B. Reconstitution of the multiprotein complex of pp60src, hsp 90 and p50 in a cell-free system. Journal of Biology Chemistry. 267(5):1992;29002-29008.
20. Kikuchi H., Hossain A., Yoshida H., Kobayashi S. Induction of cytochrome P-450 1A1 by omeprazole in human HepG2 cells is protein tyrosine kinase-dependent and is not inhibited by alpha-naphthoflavone. Archives of Biochemistry and Biophysics. 358(2):1998;351-358.
21. Kikuchi H., Hossain A. Signal transduction-mediated CYP1A1 induction by omeprazole in human HepG2 cells. Experimental and Toxicologic Pathology. 51(4-5):1999;342-346.
22. Kralisz U., Cierniewski C.S. Differential effect of the tyrosine inhibitors on collagen type-1 induced platelet aggregation and adhesion to this protein. Thrombosis Research. 86(4):1997;287-299.
23. Kuo M.L., Chau Y.P., Wang J.H., Lin P.J. The role of Src kinase in the potentiation by ethanol of cytokine- and endotoxin-mediated nitric oxide synthase expression in rat hepatocytes. Molecular Pharmacology. 52(3):1997;535-541.
24. Ledirac N., Delescluse C., de Sousa G., Pralavorio M., Lesca P., Amichot M., Bergé J.B., Rahmani R. Carbaryl induces CYP1A1 gene expression in HepG2 and HaCaT cells but is not a ligand of the human hepatic Ah receptor. Toxicology and Applied Pharmacology. 144(1):1997;177-182.
25. Lesca P., Fernandez N., Roy M. The binding components for 2,3,7,8-tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydrocarbons. Separation from the rat and mouse hepatic cytosol and characterization of a high density component. Journal of Biological Chemistry. 262(10):1987;4827-4835.
26. Lewis D.F.V. Cytochromes P450: structure, function and mechanism. First ed. 2001;Taylor and Francis, London.
27. Lind T., Cederberg C., Ekenved G., Haglund U., Olbe L. Effect of omeprazole "a gastric proton pump inhibitor" on pentagastrin stimulated acid secretion in man. Gut. 24(4):1983;270-276.
28. Ma Q., Whitlock J.P. Jr. A novel cytoplasmic protein that interact with the Ah receptor, contains tetratricopeptide repeat motif and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Journal of Biological Chemistry. 272(14):1997;8878-8884.
29. McGuire J., Whitelaw M.L., Pongratz I., Gustafsson J.Å., Poellinger L. A cellular factor stimulates ligand-dependent release of hsp90 from the basic helix-loop-helix dioxin receptor. Molecular and Cellular Biology. 14(4):1994;2438-2446.
30. Nicolas F., de Sousa G., Thomas P., Placidi M., Lorenzon G., Rahmani R. Comprarative metabolism of 3′-azido-3′-deoxythymidine in cultured hepatocytes from rats, dogs, monkeys and humans. Drug Metabolism and Disposition. 23(3):1995;308-313.
31. Park S., Henry E.C., Gasiewicz T.A. Regulation of DNA binding activity of the ligand-activated aryl hydrocarbon receptor by tyrosine phosphorylation. Archives of Biochemistry and Biophysics. 381(2):2000;302-312.
32. Poland A., Knutson J.C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annual Review of Pharmacology and Toxicology. 22:1982;517-554.
33. Quattrochi L.C., Tukey R.H. Nuclear uptake of the Ah (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene. Molecular Pharmacology. 43(4):1993;504-508.
34. Rey-Grobellet X., Ferre N., Eeckhoutte C., Larrieu G., Pineau T., Galtier P. Structural requirements for the induction of cytochrome P450 by benzimidazole anthelmenthic derivatives in cultured rabbit hepatocytes. Biochemical and Biophysical Research Communications. 220(3):1996;789-794.
35. Shih H., Pickwell G.V., Guenette D.K., Bilir B., Quattrochi L.C. Species differences in hepatocytes induction of CYP1A1 and CYP1A2 by omeprazole. Human and Experimental Toxicology. 18(2):1999;95-105.
36. Uehara Y., Fukazawa H., Murakami Y., Mizuno S. Irreversible inhibition of pp60v-src tyrosine kinase inhibitor, herbimycin A and its abrogation by sulfhydryl compounds. Biochemical and Biophysical Research Communications. 163(2):1989;803-809.
37. Whitelaw M.L., Hutchinson K., Perdew G.H. A 50-kDa cytosolic protein complexed with the 90-kDa heat shock protein (hsp90) is the same protein complexed with pp60v-src hsp90 in cells transformed by the rous sarcoma virus. Journal of Biological Chemistry. 266(25):1991;16436-16440.
38. Whitelaw M.L., McGuire J., Picard D., Gustafsson J.Å., Poellinger L. Heat shock protein hsp90 regulate dioxin receptor function in vivo. Proceedings of the National Academy of Sciences USA. 92(10):1995;4437-4441.